Logo image of WLGS

WANG & LEE GROUP INC (WLGS) Stock Fundamental Analysis

NASDAQ:WLGS - Nasdaq - VGG9T22C1003 - Common Stock - Currency: USD

0.1874  0 (-1.37%)

After market: 0.1805 -0.01 (-3.68%)

Fundamental Rating

1

WLGS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 51 industry peers in the Construction & Engineering industry. Both the profitability and financial health of WLGS have multiple concerns. WLGS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WLGS had negative earnings in the past year.
In the past year WLGS has reported a negative cash flow from operations.
WLGS Yearly Net Income VS EBIT VS OCF VS FCFWLGS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 200K -200K -400K -600K

1.2 Ratios

With a Return On Assets value of -27.06%, WLGS is not doing good in the industry: 84.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -27.06%
ROE N/A
ROIC N/A
ROA(3y)-6.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WLGS Yearly ROA, ROE, ROICWLGS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 100 200

1.3 Margins

With a decent Gross Margin value of 21.47%, WLGS is doing good in the industry, outperforming 72.55% of the companies in the same industry.
WLGS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WLGS Yearly Profit, Operating, Gross MarginsWLGS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 -10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

WLGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WLGS has been increased compared to 1 year ago.
WLGS has a better debt/assets ratio than last year.
WLGS Yearly Shares OutstandingWLGS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
WLGS Yearly Total Debt VS Total AssetsWLGS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

WLGS has an Altman-Z score of -0.20. This is a bad value and indicates that WLGS is not financially healthy and even has some risk of bankruptcy.
WLGS has a worse Altman-Z score (-0.20) than 84.31% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACCN/A
WACC8.49%
WLGS Yearly LT Debt VS Equity VS FCFWLGS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M 4M

2.3 Liquidity

A Current Ratio of 0.69 indicates that WLGS may have some problems paying its short term obligations.
WLGS has a worse Current ratio (0.69) than 82.35% of its industry peers.
WLGS has a Quick Ratio of 0.69. This is a bad value and indicates that WLGS is not financially healthy enough and could expect problems in meeting its short term obligations.
WLGS's Quick ratio of 0.69 is on the low side compared to the rest of the industry. WLGS is outperformed by 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.69
WLGS Yearly Current Assets VS Current LiabilitesWLGS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for WLGS have decreased strongly by -235.76% in the last year.
The Revenue has been growing slightly by 4.12% in the past year.
Measured over the past years, WLGS shows a quite strong growth in Revenue. The Revenue has been growing by 18.77% on average per year.
EPS 1Y (TTM)-235.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-432.67%
Revenue 1Y (TTM)4.12%
Revenue growth 3Y18.77%
Revenue growth 5YN/A
Sales Q2Q%14.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WLGS Yearly Revenue VS EstimatesWLGS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2M 4M 6M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WLGS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WLGS Price Earnings VS Forward Price EarningsWLGS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WLGS Per share dataWLGS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WLGS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WANG & LEE GROUP INC

NASDAQ:WLGS (4/17/2025, 8:00:02 PM)

After market: 0.1805 -0.01 (-3.68%)

0.1874

0 (-1.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.93%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.97M
AnalystsN/A
Price TargetN/A
Short Float %4.34%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.26
BVpS-0.08
TBVpS-0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.47%
FCFM N/A
ROA(3y)-6.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.69
Altman-Z -0.2
F-Score4
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-235.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-432.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.12%
Revenue growth 3Y18.77%
Revenue growth 5YN/A
Sales Q2Q%14.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-77.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.93%
OCF growth 3YN/A
OCF growth 5YN/A